Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Delphine Planas, David Veyer, Artem Baidaliuk, +26

Nature

Reduced SensitivityVaccine TargetImmunologyAntibody EngineeringImmunotherapy +2

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

Delphine Planas, Nell Saunders, Piet Maes, +29

Nature

Vaccine TargetImmunologyAntibody ScreeningAntibody EngineeringImmunotherapy +2

Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals

Delphine Planas, David Veyer, Artem Baidaliuk, +26

Viral DiagnosticsImmunologyImmunodominanceCovid-19Viral Evolution +14

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

Delphine Planas, Nell Saunders, Piet Maes, +29

Nature

Vaccine TargetImmunologyAntibody ScreeningAntibody EngineeringImmunotherapy +2

Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies

Delphine Planas, Timothée Bruel, Isabelle Staropoli, +22

Nature Communications

Considerable escape of SARS-CoV-2 variant Omicron to antibody neutralization

Delphine Planas, Nell Saunders, Piet Maes, +29

Viral DiagnosticsImmunodeficienciesImmunologyImmunodominanceCovid-19 +16

Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection

Delphine Planas, Isabelle Staropoli, Françoise Porot, +14

Med

VaccinationMucosal VaccinationVaccine DevelopmentNasal SwabsImmunology +6

Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies

Delphine Planas, Timothée Bruel, Isabelle Staropoli, +22

ImmunodeficienciesImmunologyViral PathogenesisImmunodominanceImmunotherapeutics +16

High Prevalence of Anal and Oral High-Risk Human Papillomavirus in Human Immunodeficiency Virus–Uninfected French Men Who Have Sex With Men and Use Preexposure Prophylaxis

Ralph‐Sydney Mboumba Bouassa, Laurent Bélec, C. Gubavu, +9

Open Forum Infectious Diseases

Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study

Blandine Monel, Delphine Planas, Ludivine Grzelak, +24

EBioMedicine